Navigation Links
Implantable Glucose Sensor Featuring IDT Sensing Technology Awarded CE Mark

SAN JOSE, Calif., June 22, 2016  Integrated Device Technology, Inc. (IDT) (NASDAQ: IDTI)  announced today that an implantable long-term glucose sensor using IDT's sensing technology has received government approval to be marketed in European Union (EU) member countries. Maryland-based Senseonics received the CE Mark approval for its Eversense® Continuous Glucose Monitoring (CGM) System, featuring an implanted glucose sensor that lasts up to 90 days, or about six times longer than non-implantable systems currently on the market.

The IDT® sensing solution incorporates an LED driver, temperature sensor, photodiodes and other components in a compact package to drive glucose measurements, which are wirelessly communicated to an on-body wearable transmitter.

"Anyone treating diabetes knows all too well the importance of keeping close watch of glucose levels," said Dr. Andrew Dehennis, director of engineering at Senseonics. "IDT provides a unique semiconductor-based technology with extremely low power consumption, enabling the Eversense system to help the millions of people with diabetes looking for a long-lasting, accurate, easy-to-use continuous glucose monitoring system."

In developing the semiconductor for Senseonics, IDT engineers selected a technology usually used for hearing aids that can be operated at a voltage as low as 0.85 V.

"Senseonics' use of our novel technology to develop its Eversense CGM system is a great example of how miniaturized advanced electronics are contributing to improvements in medical care," said Uwe Guenther, director of mobile sensing at IDT. "The IDT technology used provides an unparalleled level of system integration to deliver the requisite quality and reliability—all in one implantable single-chip solution."

The biotech company Roche announced last month that it will market the Eversense CGM System in Italy, Germany and the Netherlands.

About IDT

Integrated Device Technology, Inc. develops system-level solutions that optimize its customers' applications. IDT's market-leading products in RF, timing, wireless power transfer, serial switching, interfaces and sensing solutions are among the company's broad array of complete mixed-signal solutions for the communications, computing, consumer, automotive and industrial segments. Headquartered in San Jose, Calif., IDT has design, manufacturing, sales facilities and distribution partners throughout the world. IDT stock is traded on the NASDAQ Global Select Stock Market® under the symbol "IDTI." Additional information about IDT is accessible at Follow IDT on Facebook, LinkedIn, Twitter, YouTube and Google+.

About Senseonics

Senseonics Holdings, Inc. is a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to help people with diabetes confidently live their lives with ease. Senseonics' first generation continuous glucose monitoring system, Eversense®, includes a small sensor, smart transmitter and mobile application. Based on fluorescence sensing technology, the sensor is designed to be inserted subcutaneously and communicate with the smart transmitter to wirelessly transmit glucose levels to a mobile device. After insertion, the sensor is designed to continually and accurately measure glucose levels. For more information on Senseonics, please visit

2016, IDT. IDT and the IDT logo are trademarks or registered trademarks of Integrated Device Technology, Inc. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

IDT Press Contact:
Dean Solov
Public Relations Manager
Phone: (408) 284-2608

Logo -


To view the original version on PR Newswire, visit:

SOURCE Integrated Device Technology, Inc.
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Key Growth Drivers That Will Take the Biomaterials Market for Implantable Devices to US$33,600 Million by 2019: Transparency Market Research
2. Snapshot of Innovations in R&D Targeting Key Applications of Drug Delivery Technologies - Oral Route, Pulmonary, Topical, Implantable, Injectable, Transdermal & Transmucosal Route Analysis
3. Allergan Successfully Completes AqueSys Acquisition, Adding XEN45 Minimally Invasive Implantable Shunt for Glaucoma
4. Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering
5. Global Implantable Medical Devices Market 2015-2019
6. Microsemis New RF Module Speeds Time-to-Market for Implantable Medical Device Designers
7. Global Defibrillators Market 2015-2019 - Analysis of $12 Billion Implantable Cardioverter Defibrillator and External Defribillators Market
8. Global Implantable Infusion Pumps Market Analysis 2015-2018
9. Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research
10. Defibrillators Market (Advanced Life Support, Automated External Defibrillators, Implantable Cardioverter Defibrillators, Wearable Defibrillators) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
11. Implantable Medical Device Group formed to Reduce Risk and Simplify Management of Active Implant Projects
Post Your Comments:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):